Clinical Trial Update: Investigating the Safety and Regenerative Potential of MSC-Derived Secretome Combined With PRGF in Knee Osteoarthritis [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial is investigating the safety and regenerative potential of mesenchymal stem cell-derived secretome combined with platelet-rich gr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cartilage Degeneration
• Knee Injury
• Osteoarthritis

Drugs mentioned

• MSC-derived secretome
• PRGF (platelet-rich growth factor)

Snippet

Sponsor: University of the Punjab | Conditions: Osteoarthritis (OA), Knee Injury | EARLY_Phase 1 | Status: NOT_YET_RECRUITING